Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
2010
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
2009
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
3D‐Printed Microfluidics
2016
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer
2009
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
Inhibition of transcription by platinum antitumor compounds
2009
Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l
2005
Vulvovaginal candidosis
2007 Standout
Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
2006
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
Ovarian cancer
2014 Standout
Microfluidics for food, agriculture and biosystems industries
2011
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
2007
The metabolic syndrome
2010 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Statins and C‐Reactive Protein Levels
2007
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Neuroimaging as a Guide to Predict Outcomes for Patients with Coccidioidal Meningitis
2005
Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
2011
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study
2005
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Coccidioidomycosis
1995
Echinocandin antifungal drugs
2003 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)
2007
Coccidioidomycosis
2004
Coccidioides immitispresenting as a mycelial pathogen with empyema and hydropneumothorax
1992
Safety of Aggressive Lipid Management
2007
Statin-Associated Myopathy
2003
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials
2007
Low-Density Lipoprotein-Dependent and -Independent Effects of Cholesterol-Lowering Therapies on C-Reactive Protein
2007
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Outcomes After Multiple Lines of Chemotherapy for Platinum-Resistant Epithelial Cancers of the Ovary, Peritoneum, and Fallopian Tube
2010
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Nonfilamentous C. albicans Mutants Are Avirulent
1997 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Serology of coccidioidomycosis
1990
Fluorine in medicinal chemistry
2007 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Rapid Diagnostic Assay for Intact Influenza Virus Using a High Affinity Hemagglutinin Binding Protein
2017 StandoutNobel
Correlation between Antifungal Susceptibilities of Coccidioides immitis In Vitro and Antifungal Treatment with Caspofungin in a Mouse Model
2001
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
2011
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Comparison of Oral Fluconazole and Itraconazole for Progressive, Nonmeningeal Coccidioidomycosis
2000
Gold nanoparticle-based lateral flow assay for detection of staphylococcal enterotoxin B
2009
Coccidioidomycosis: Host Response and Vaccine Development
2004
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Identification of a17β-estradiol binding protein inCandida albicans andCandida (Torulopsis) glabrata
1984
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Point of Care Diagnostics: Status and Future
2011
Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2003
Comparison of Itraconazole and Fluconazole Treatments in a Murine Model of Coccidioidal Meningitis
2006
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice
1992
Efficacy of Intravenous Liposomal Amphotericin B (AmBisome) against Coccidioidal Meningitis in Rabbits
2002
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis
2015
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
2008
Emerging Droplet Microfluidics
2017 Standout
Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis
2013
Clinical Translation of Nanomedicine
2015
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
The Discovery of Ezetimibe: A View from Outside the Receptor
2003
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
Works of Steven Sun being referenced
Predictors of Efficacy and Health Resource Utilization in Treatment of Complicated Intra-abdominal Infections: Evidence for Pooled Clinical Studies Comparing Tigecycline with Imipenem–Cilastatin
2007
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
2004
A fluorescence detection platform using spatial electroluminescent excitation for measuring botulinum neurotoxin A activity
2008
Lab-on-a-chip for botulinum neurotoxin a (BoNT-A) activity analysis
2009
An automated point-of-care system for immunodetection of staphylococcal enterotoxin B
2011
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
2002
Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of murine coccidioidal meningitis
1992
Activity of Cilofungin against Coccidioides immitis: Differential In Vitro Effects on Mycelia and Spherules Correlated with In Vivo Studies
1990
Miniaturized 96-well ELISA chips for staphylococcal enterotoxin B detection using portable colorimetric detector
2009
ELISA-LOC: lab-on-a-chip for enzyme-linked immunodetection
2010
Efficacy of AmBisome in murine coccidioidomycosis
1994
Common antigens among systemic disease fungi analyzed by two-dimensional immunoelectrophoresis
1979
Electron microscopic studies of saprobic and parasitic forms ofCoccidioides immitis
1979
Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy
1983
Treatment of murine coccidioidal meningitis with SCH39304
1990
Comparison of Coccidioidin and Spherulin in Complement Fixation Tests for Coccidioidomycosis
1977
Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis
1978
Isolation and morphology of an immunoreactive outer wall fraction produced by spherules of Coccidioides immitis
1988
Early Changes in CA125 After Treatment with Pegylated Liposomal Doxorubicin or Topotecan Do Not Always Reflect Best Response in Recurrent Ovarian Cancer Patients
2007
Specificity of exoantigens for identifying cultures of Coccidioides immitis
1978
Delayed-type hypersensitivity responses to a cell wall fraction of the mycelial phase of Coccidioides immitis
1975
Human sex hormones stimulate the growth and maturation of Coccidioides immitis
1981
An immunoreactive apoglycoprotein purified from Coccidioides immitis
1991
Immunoreactivity of a surface wall fraction produced by spherules of Coccidioides immitis
1988
The Critical Role of CO2 in the Morphogenesis of Coccidioides immitis in Cell-Free Subcutaneous Chambers
1984
Evaluation of a Latex Particle Agglutination test for Coccidioidomycosis
1968
Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
2003
Resistance of Vaccinated Mice to Typical and Atypical Strains ofCoccidioides immitis
1967
Isolation of antigens with proteolytic activity from Coccidioides immitis
1989
An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis
1987
An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination
1992
Morphogenesis throughout saprobic and parasitic cycles of Coccidioides immitis
1982